News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,964 Results
Type
Article (87430)
Company Profile (760)
Press Release (772751)
Multimedia
Podcasts (172)
Webinars (28)
Section
Business (233053)
Career Advice (4139)
Deals (39795)
Drug Delivery (136)
Drug Development (91249)
Employer Resources (203)
FDA (18284)
Job Trends (17399)
News (397389)
Policy (39926)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (125)
Alliances (56979)
ALS (146)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (244)
Approvals (18308)
Artificial intelligence (489)
Autoimmune disease (75)
Automation (26)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (160)
Biotechnology (484)
Bladder cancer (132)
Brain cancer (52)
Breast cancer (505)
Cancer (3962)
Cardiovascular disease (339)
Career advice (3556)
Career pathing (38)
CAR-T (247)
CDC (57)
Cell therapy (684)
Cervical cancer (33)
Clinical research (75520)
Collaboration (1387)
Company closure (4)
Compensation (939)
Complete response letters (59)
COVID-19 (2956)
CRISPR (81)
C-suite (591)
Cystic fibrosis (135)
Data (4490)
Decentralized trials (2)
Denatured (61)
Depression (112)
Diabetes (455)
Diagnostics (7091)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (233)
Drug pricing (190)
Drug shortages (36)
Duchenne muscular dystrophy (203)
Earnings (98801)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (133003)
Executive appointments (991)
FDA (20751)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1256)
Gene editing (173)
Generative AI (48)
Gene therapy (546)
GLP-1 (1020)
Government (5384)
Grass and pollen (7)
Guidances (342)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (63)
Immunology and inflammation (242)
Immuno-oncology (20)
Indications (53)
Infectious disease (3197)
Inflammatory bowel disease (187)
Inflation Reduction Act (15)
Influenza (97)
Intellectual property (189)
Interviews (815)
IPO (17926)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (16)
Labor market (77)
Layoffs (640)
Leadership (33)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (572)
Lymphoma (265)
Machine learning (30)
Management (66)
Manufacturing (637)
MASH (140)
Medical device (14871)
Medtech (14894)
Mergers & acquisitions (22746)
Metabolic disorders (1158)
Multiple sclerosis (138)
NASH (23)
Neurodegenerative disease (228)
Neuropsychiatric disorders (60)
Neuroscience (2715)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (57)
Obesity (558)
Opinion (312)
Ovarian cancer (135)
Pain (166)
Pancreatic cancer (172)
Parkinson's disease (242)
Partnered (30)
Patents (419)
Patient recruitment (311)
Peanut (57)
People (66259)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23293)
Phase II (32781)
Phase III (24697)
Pipeline (2726)
Policy (295)
Postmarket research (3554)
Preclinical (10500)
Press Release (72)
Prostate cancer (201)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (673)
Real estate (7421)
Recruiting (78)
Regulatory (28017)
Reports (65)
Research institute (2690)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (71)
Schizophrenia (135)
Series A (207)
Series B (156)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (95)
The Weekly (109)
Vaccines (1047)
Venture capital (66)
Weight loss (396)
Women's health (59)
Worklife (21)
Date
Today (148)
Last 7 days (699)
Last 30 days (2555)
Last 365 days (33603)
2025 (26500)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50976)
Australia (8959)
California (9457)
Canada (2860)
China (901)
Colorado (401)
Connecticut (423)
Delaware (271)
Europe (117118)
Florida (1393)
Georgia (316)
Hawaii (3)
Idaho (67)
Illinois (813)
India (51)
Indiana (461)
Iowa (19)
Japan (324)
Kansas (124)
Kentucky (38)
Louisiana (20)
Maine (78)
Maryland (1278)
Massachusetts (7124)
Michigan (314)
Minnesota (563)
Mississippi (4)
Missouri (119)
Montana (33)
Nebraska (26)
Nevada (108)
New Hampshire (77)
New Jersey (2630)
New Mexico (32)
New York (2578)
North Carolina (1412)
North Dakota (10)
Northern California (4278)
Ohio (297)
Oklahoma (22)
Oregon (50)
Pennsylvania (1967)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (49)
South Dakota (1)
Southern California (3614)
Tennessee (149)
Texas (1483)
United States (34991)
Utah (283)
Virginia (249)
Washington D.C. (83)
Washington State (818)
West Virginia (4)
Wisconsin (97)
Wyoming (1)
There are 860,964 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Patient-Reported Outcomes from VERITAC-2 Clinical Trial Support Clinical Benefit of Vepdegestrant in Patients with ESR1-Mutated, ER+/HER2- Advanced or Metastatic Breast Cancer Previously Treated with Endocrine-Based Therapy
October 21, 2025
·
9 min read
Press Releases
Coloplast A/S - FY 2024/25 Earnings Release - Invitation for conference call on 4 Nov 2025 at 11.00 CET
October 21, 2025
·
1 min read
Press Releases
GRAIL, Inc. Announces $325.0 Million Private Placement Financing
October 21, 2025
·
5 min read
Press Releases
IDEAYA Biosciences Announces Positive Phase 2 Data for Darovasertib in the Neoadjuvant Setting of Primary Uveal Melanoma in a Proffered Paper Oral Presentation at ESMO 2025
October 21, 2025
·
9 min read
Press Releases
New One-Year Data Reinforcing the Robust and Sustained Efficacy of EMPAVELI® (pegcetacoplan) in C3G and Primary IC-MPGN to be Presented at ASN Kidney Week
October 21, 2025
·
16 min read
Press Releases
Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
October 21, 2025
·
4 min read
Press Releases
Medicenna Therapeutics Announces Participation in Upcoming Conferences - October 20, 2025
October 21, 2025
·
4 min read
Press Releases
BPGbio and Icahn School of Medicine at Mount Sinai Publish Landmark Study on the Living Human Brain, Unlocking New Molecular Insights Into Neurodegenerative Disease
October 21, 2025
·
4 min read
Press Releases
CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance
October 21, 2025
·
6 min read
Press Releases
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
October 21, 2025
·
5 min read
1 of 86,097
Next
